DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Dobri N, Qin Q, Kong J. et al.
A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
Invest Ophthalmol Vis Sci 2013;
54: 85-95
doi:10.1167/iovs.12-10050
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.